1. Home
  2. AMPH vs ATEN Comparison

AMPH vs ATEN Comparison

Compare AMPH & ATEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • ATEN
  • Stock Information
  • Founded
  • AMPH 1996
  • ATEN 2004
  • Country
  • AMPH United States
  • ATEN United States
  • Employees
  • AMPH N/A
  • ATEN N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • ATEN EDP Services
  • Sector
  • AMPH Health Care
  • ATEN Technology
  • Exchange
  • AMPH Nasdaq
  • ATEN Nasdaq
  • Market Cap
  • AMPH 1.3B
  • ATEN 1.5B
  • IPO Year
  • AMPH 2014
  • ATEN 2014
  • Fundamental
  • Price
  • AMPH $28.29
  • ATEN $16.62
  • Analyst Decision
  • AMPH Hold
  • ATEN Buy
  • Analyst Count
  • AMPH 3
  • ATEN 2
  • Target Price
  • AMPH $43.50
  • ATEN $21.00
  • AVG Volume (30 Days)
  • AMPH 569.1K
  • ATEN 1.8M
  • Earning Date
  • AMPH 05-07-2025
  • ATEN 04-29-2025
  • Dividend Yield
  • AMPH N/A
  • ATEN 1.46%
  • EPS Growth
  • AMPH 17.69
  • ATEN 26.41
  • EPS
  • AMPH 3.06
  • ATEN 0.67
  • Revenue
  • AMPH $731,967,000.00
  • ATEN $261,696,000.00
  • Revenue This Year
  • AMPH $2.60
  • ATEN $9.39
  • Revenue Next Year
  • AMPH $9.42
  • ATEN $7.96
  • P/E Ratio
  • AMPH $9.25
  • ATEN $24.57
  • Revenue Growth
  • AMPH 13.59
  • ATEN 3.97
  • 52 Week Low
  • AMPH $25.89
  • ATEN $12.27
  • 52 Week High
  • AMPH $53.96
  • ATEN $21.90
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 43.50
  • ATEN 35.01
  • Support Level
  • AMPH $28.01
  • ATEN $16.11
  • Resistance Level
  • AMPH $29.18
  • ATEN $17.98
  • Average True Range (ATR)
  • AMPH 0.79
  • ATEN 0.60
  • MACD
  • AMPH 0.35
  • ATEN -0.10
  • Stochastic Oscillator
  • AMPH 72.95
  • ATEN 30.61

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

Share on Social Networks: